Asante Solutions Inc (NASDAQ:PUMP) – Equities researchers at Piper Jaffray Companies dropped their Q3 2018 earnings per share estimates for shares of Asante Solutions in a research report issued to clients and investors on Sunday, July 1st. Piper Jaffray Companies analyst J. Daniel now anticipates that the company will post earnings per share of $0.48 for the quarter, down from their previous estimate of $0.50. Piper Jaffray Companies currently has a “Buy” rating and a $19.00 target price on the stock. Piper Jaffray Companies also issued estimates for Asante Solutions’ FY2018 earnings at $1.83 EPS, Q1 2019 earnings at $0.40 EPS, Q2 2019 earnings at $0.39 EPS, Q3 2019 earnings at $0.41 EPS and FY2019 earnings at $1.68 EPS.
Get Asante Solutions alerts:PUMP has been the topic of a number of other research reports. Royal Bank of Canada set a $20.00 target price on Asante Solutions and gave the company a “buy” rating in a report on Wednesday, March 28th. Macquarie assumed coverage on Asante Solutions in a report on Friday, June 8th. They issued a “neutral” rating and a $17.00 target price on the stock. Tudor Pickering downgraded Asante Solutions from a “buy” rating to a “hold” rating in a report on Friday, June 8th. Cowen reaffirmed a “market perform” rating and issued a $14.00 target price (up previously from $13.00) on shares of Asante Solutions in a report on Thursday, May 10th. Finally, Jefferies Financial Group set a $21.00 target price on Asante Solutions and gave the company a “buy” rating in a report on Tuesday, March 27th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $21.73.
Shares of PUMP stock opened at $15.63 on Wednesday. Asante Solutions has a fifty-two week low of $10.84 and a fifty-two week high of $22.88.
Asante Solutions (NASDAQ:PUMP) last issued its earnings results on Tuesday, May 8th. The company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.04. The business had revenue of $385.20 million during the quarter, compared to analyst estimates of $375.75 million. The company’s revenue for the quarter was up 124.1% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.43) EPS.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Hancock Holding Co. lifted its stake in shares of Asante Solutions by 1.2% in the 1st quarter. Hancock Holding Co. now owns 520,980 shares of the company’s stock valued at $8,279,000 after acquiring an additional 6,005 shares during the last quarter. New York State Common Retirement Fund lifted its stake in shares of Asante Solutions by 22.3% in the 1st quarter. New York State Common Retirement Fund now owns 62,000 shares of the company’s stock valued at $985,000 after acquiring an additional 11,300 shares during the last quarter. GW&K Investment Management LLC bought a new position in shares of Asante Solutions in the 1st quarter valued at $224,000. Metropolitan Life Insurance Co. NY bought a new position in shares of Asante Solutions in the 4th quarter valued at $378,000. Finally, American International Group Inc. lifted its stake in shares of Asante Solutions by 126.9% in the 4th quarter. American International Group Inc. now owns 38,425 shares of the company’s stock valued at $775,000 after acquiring an additional 21,491 shares during the last quarter.
In other news, Director Pryor Blackwell purchased 13,404 shares of the company’s stock in a transaction dated Thursday, June 7th. The stock was bought at an average cost of $15.36 per share, for a total transaction of $205,885.44. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
About Asante Solutions
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
No comments:
Post a Comment